The CSDA will provide Dr. Dupnik with $495,000 over three years in support of her research studies in the area of infectious diseases.
This award is presented annually to members of the Weill Department of Medicine below the rank of professor who perform on outstanding levels in the areas of clinical and/or basic biomedical research.
Initiated in 2002, the award is given to fellows within the Weill Department of Medicine who have performed outstanding research. This year's finalists were presented at Medicine Grand Rounds on June 19.
Five winners in the Weill Department of Medicine have been selected to receive Fund for the Future awards to pursue a wide range of breakthrough research.
This award was founded to encourage outstanding research in women’s health. The finalists presented their work at Medicine Grand Rounds.
Building upon the division’s strong legacy in the field of Inflammatory Bowel Disease (IBD), Dr. Longman will oversee and expand clinical, research and educational activities at the JRC.
The innate immune system is the body’s first line of defense against invading pathogens, but there has been a lack of information on what a “healthy” innate immune system looks like.
Pembrolizumab was administered to patients who had already undergone extensive chemotherapy for advanced esophageal cancer and who, subsequently, had not responded to any other treatment.
The newsletter’s feature was in recognition of Dr. Lee’s pivotal abstract that presented an evaluation of the gut microbiota in 169 kidney transplant recipients.
This therapy is primarily being studied for resistant prostate cancer that has spread and/or has not responded to hormonal therapy.
